Results 141 to 150 of about 76,188 (198)

Efficacy and safety of the third-generation tyrosine kinase inhibitor Olverembatinib in relapsed and persistent minimal residual disease positive Philadelphia chromosome-positive acute lymphoblastic leukemia patients. [PDF]

Front Med (Lausanne)
Jiang X, Zhou M, Ma J, Ji Q, Li X, Ma S, Chen C.   +6 more
europepmc   +1 more source

Management of Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia in a Jehovah's Witness using chemotherapy free regimen: A case report and review of literature. [PDF]

Leuk Res Rep
Raza MH, Khan E, Desjarlais AM, Fazal S.
europepmc   +1 more source

Successful Allogeneic Stem Cell Transplant for Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia After Pneumonectomy for Pulmonary Mucormycosis: A Case Report and Review of the Literature. [PDF]

EJHaem
O'Hara A, Zepcan S, Tsai S, Puthawala I, Kosti-Schwartz J.   +4 more
europepmc   +1 more source

Dasatinib and CAR T-Cell Therapy in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Nonrandomized Clinical Trial.

JAMA Oncol
Zhang M, Fu S, Feng J, Hong R, Wei G, Zhao H, Zhao M, Xu H, Cui J, Huang S, Wu X, Liu L, Sun J, Wu W, Zhu Y, He J, Zhao Y, Cai Z, Zheng W, Ye X, Shi J, Luo Y, Wang D, Chang AH, Hu Y, Huang H.   +25 more
europepmc   +1 more source

How I treat Philadelphia chromosome-like acute lymphoblastic leukemia in children, adolescents, and young adults.

Blood
Tran TH, Tasian SK.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

THE PHILADELPHIA CHROMOSOME

Lancet, The, 1964
A G Baikie
exaly   +4 more sources